Alyacen 1/35 Kit
Product Images NDC 68462-394

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Alyacen 1/35 (NDC 68462-394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1-35-carton (1 35 Carton)

ALYACEN 1/35 (norethindrone and ethinyl estradiol) tablets USP 1 mg/0.035 mg kit, containing 3 blister cards with 28 tablets each. The carton front displays the proprietary name, active ingredients, strength, quantity, and RX only status. The side panel includes dosage information, storage instructions, manufacturer details (Glenmark Pharmaceuticals, India and USA), and a caution that the package is not child resistant.*

FDA Label Image

1-35-pouch (1 35 Pouch)

Packaging label for ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg), a prescription oral contraceptive kit. The label indicates it contains 1 blister card with 28 tablets. Manufactured by Glenmark Pharmaceuticals Inc., USA, with additional manufacturing noted from India. Includes storage instructions and a barcode.*

FDA Label Image

777-carton (777 Carton)

ALYACEN 7/7/7 kit containing norethindrone and ethinyl estradiol tablets in strengths of 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, and 1 mg/0.035 mg. The label indicates a 28-day regimen with 3 blister cards, each holding 28 tablets, by Glenmark Pharmaceuticals Inc., USA. Storage instructions and a barcode are also visible.*

FDA Label Image

777-pouch (777 Pouch)

ALYACEN 7/7/7 kit containing norethindrone and ethinyl estradiol tablets in multiple strengths (0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg). The label shows 1 blister card with 28 tablets. Manufactured by Glenmark Pharmaceuticals Ltd., India, and marketed by Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Image001 (9f6ca0ec 20a5 4e5b 90e2 8117763685ca 00)

FDA Label Image

Structure (Image 01)

Chemical structure diagrams of Norethindrone and Ethinyl estradiol, the active ingredients in the product ALYACEN 7/7/7. Each structure is labeled with the respective ingredient name and USP designation.*

FDA Label Image

Figure1 (Image 02)

A bar chart illustrating mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45+) for four categories: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). The chart shows higher mortality in ever-users who smoke, especially in older age groups.*

FDA Label Image

Bs-image1 (Image 03)

ALYACEN 7/7/7 oral contraceptive kit by Glenmark Pharmaceuticals Inc., USA, showing a weekly pill organizer with four rows labeled Week 1 to Week 4 and days Sunday to Saturday. The kit contains white to off-white, light peach, peach (all active hormone) pills, and light green inactive pills totaling 28 tablets.*

FDA Label Image

Bs-image3 (Image 04)

ALYACEN 7/7/7 kit blister pack containing norethindrone and ethinyl estradiol tablets USP 1 mg/0.035 mg. The pack is organized by week, with 21 active peach pills followed by 7 inactive light green pills, labeled for daily use from Sunday to Saturday. The labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Bs-image2 (Image 05)

An instructional illustration for the ALYACEN 7/7/7 oral contraceptive kit by Glenmark Pharmaceuticals Inc., USA, showing a hand placing a labeled day strip over the blister pack. The kit is organized into weeks and days with circles representing tablet positions, and includes dosage information for norethindrone and ethinyl estradiol tablets.*

FDA Label Image

Bs-image4 (Image 06)

An instructional diagram showing a hand peeling and placing a day label on a medication pack. The pack is labeled ALYACEN 1/35, containing norethindrone and ethinyl estradiol tablets, with days of the week listed on the label strip. The pack is divided into four weeks with tablet compartments for each day to guide proper daily dosing.*

FDA Label Image

Dpl-image1 (Image 07)

ALYACEN 7/7/7 birth control pill kit label showing weekly pill layout. The kit includes white to off-white active pills, light peach active pills, peach active pills, and light green inactive pills arranged in a 28-day cycle. The label displays dose information for norethindrone and ethinyl estradiol tablets.*

FDA Label Image

Dpl-image3 (Image 08)

ALYACEN 7/7/7 Kit containing norethindrone and ethinyl estradiol tablets USP, 1 mg/0.035 mg. The image shows a 28-day blister pack divided into four weekly rows with days of the week labeled, peach active pills for the first three weeks, and light green inactive pills for the fourth week. The labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Dpl-image2 (Image 09)

An instructional diagram showing a hand placing a correct day label on an ALYACEN 7/7/7 norethindrone and ethinyl estradiol tablet kit. The kit includes a 4-week calendar with weekly compartments for tablets and space to place the removable day label starting from Tuesday.*

FDA Label Image

Dpl-image4 (Image 10)

Instructional illustration showing a hand placing a day label strip on the ALYACEN 1/35 tablet kit. The label strip lists days of the week to align with the rows of tablets organized by weeks, guiding proper day identification for medication intake.*

FDA Label Image

Logo (Image 11)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.